...
首页> 外文期刊>Vaccine >Microparticles in MF59, a potent adjuvant combination for a recombinantprotein vaccine against HIV-1
【24h】

Microparticles in MF59, a potent adjuvant combination for a recombinantprotein vaccine against HIV-1

机译:MF59中的微粒,一种针对HIV-1的重组蛋白疫苗的有效佐剂组合

获取原文
获取原文并翻译 | 示例
           

摘要

Novel adjuvant formulations involving PLG microparticles with entrapped recombinant protein antigens (env gp120 and p24 gag) from human immunodeficiency virus type-1 (HIV-1), dispersed in the emulsion adjuvant MF59 were evaluated as potential HIV-1 vaccine candidates in mice and baboons. In mice, the adjuvant combination induced significantly enhanced antibody responses in comparison to either adjuvant used alone. In addition, the polylactide co-glycolide polymer (PLG) microparticles and MF59 combination induced CTL activity against HIV-1 p24 gag. In baboons, the adjuvant combination induced significantly enhanced antibody titers after a single dose of gp120, but the responses were comparable to gp120 in MF59 alone after boosting. Both MF59 + gp120 alone and PLG/gp120 in MF59 induced neutralizing antibodies against a T cell line-adapted (TCLA) strain and a primary isolate of HIV-1. In contrast to the observations with gp120, immunization in baboons with PLG/p24 in MF59 induced significantly enhanced antibody responses after boosting, in comparison to immunization with MF59 alone + p24.
机译:包含PLG微粒的新型佐剂制剂被分散在乳剂佐剂MF59中,该佐剂包含来自人类免疫缺陷病毒1型(HIV-1)的捕获的重组蛋白抗原(env gp120和p24 gag),被评估为在小鼠和狒狒中可能的HIV-1候选疫苗。与单独使用的任一佐剂相比,佐剂组合在小鼠中诱导的抗体反应显着增强。此外,聚丙交酯乙交酯聚合物(PLG)微粒和MF59组合诱导了针对HIV-1 p24 gag的CTL活性。在狒狒中,佐剂组合在单剂gp120后诱导明显提高的抗体效价,但加强后的反应与单独MF59中的gp120相当。单独的MF59 + gp120和MF59中的PLG / gp120均可诱导针对T细胞系适应性(TCLA)菌株和HIV-1主要分离株的中和抗体。与用gp120观察到的结果相反,与单独用MF59 + p24免疫相比,在MF59中用PLG / p24在狒狒中免疫可诱导增强后的抗体应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号